Menu

Logo
Edgemont Capital Partners

Investment Bank

New York, New York HQ

Member since
2013
Deals they've closed
59
About
Edgemont Capital Partners is a leading independent investment banking firm to the healthcare and life sciences industries. We focus on the needs of entrepreneurs, founders, owners and their investors of lower middle through middle market companies. We provide sell-side and buy-side mergers and acqui…
Team (5)
Recent Transactions (59)
Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Clinical Research Institute of Southern Oregon

in securing investment from

NaviMed Capital

December 2017

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

New Horizons Clinical Research

in securing investment from

NaviMed Capital

December 2017

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Brain Matters Research

in their acquisition by

Evolution Research Group

November 2017

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Endeavor Clinical Trials

in their acquisition by

Evolution Research Group

July 2017

Edgemont Capital Partners
Health Care Services
Advised

Northside Emergency Associates

in their acquisition by

Envision Healthcare

June 2017

Edgemont Capital Partners
Health Care Services
Advised

Skin and Beauty Center

in securing investment from

Gemini Investors

March 2017

Edgemont Capital Partners
Health Care Services
Advised

Florida Emergency Physicians

in their acquisition by

TeamHealth

October 2016

Edgemont Capital Partners
Health Care Services
Advised

Associated Anesthesiologists of Reno

in their acquisition by

MEDNAX

August 2016

Edgemont Capital Partners
Health Care Services
Advised

Compass Research

in their acquisition by

Bioclinica

July 2016

Edgemont Capital Partners
Health Care Services
Advised

Premier Emergency Medical Specialists

in their acquisition by

Sheridan

December 2015

Edgemont Capital Partners
Health Care Services
Advised

Anesthesia Services Associates

in their acquisition by

PhyMed

November 2015

Edgemont Capital Partners
Health Care Services
Advised

Workwell Medical Group

in securing investment from

Salt Creek Capital

October 2015

Edgemont Capital Partners
Health Care Services
Advised

New Jersey Anesthesia Associates

in their acquisition by

MEDNAX

September 2015

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

Scynexis' Service Business

in their acquisition by

Avista Pharma

July 2015

Edgemont Capital Partners
Drugs and Druggists' Sundries Distributors (Wholesalers), Health Care Services, Medical, Dental, and Hospital Equipment and Supplies Distributors (Wholesalers), Ophthalmic Goods Distributors (Wholesalers), Research and Development in Biotechnology
Advised

Burman's Specialty Pharmacy

in their acquisition by

Diplomat Pharmacy

June 2015

Edgemont Capital Partners
Drugs and Druggists' Sundries Distributors (Wholesalers), Health Care Services, Medical, Dental, and Hospital Equipment and Supplies Distributors (Wholesalers), Ophthalmic Goods Distributors (Wholesalers), Research and Development in Biotechnology
Advised

BioRx

in their acquisition by

Diplomat Pharmacy

February 2015

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Siren Interactive

in their acquisition by

Dohmen

December 2014

Edgemont Capital Partners
Health Care Services
Advised

Premier Physician Services

in their acquisition by

TeamHealth

October 2014

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Woodland International Research

in securing investment from

DFW Capital Partners

April 2014

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Thievon-Wright Consulting Group

in securing investment from

DFW Capital Partners

April 2014

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

St. Louis Clinical Trials

in securing investment from

DFW Capital Partners

April 2014

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

MediMedia Health

in their acquisition by

J. Knipper & Co

January 2014

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Community Research

in their acquisition by

CTI Clinical Trial & Consulting

January 2014

Edgemont Capital Partners
Health Care Services
Advised

Wolverine Anesthesia Consultants

in their acquisition by

TeamHealth

November 2013

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Vince & Associates Clinical Research

in their acquisition by

Altasciences

May 2013

Edgemont Capital Partners
Health Care Services
Advised

Practice Support Resources, LLC

in their acquisition by

Intermedix Corporation

January 2013

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Sample Management and Fulfillment Division of inVentiv Health

in their acquisition by

J. Knipper & Co

January 2013

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Miami Research Associates

in their acquisition by

QPS Holdings

December 2012

Edgemont Capital Partners
Health Care Services
Advised

South Oakland Anesthesia Associates

in their acquisition by

Mednax

December 2012

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

PSKW

in securing investment from

Owners and Management

January 2012

Edgemont Capital Partners
Hospitals, Nursing and Residential Care Facilities, Research and Development in the Physical, Engineering, and Life Sciences, Veterinary Services
Advised

ACORN Clinical Research

in securing investment from

Strategic Investor

December 2011

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

Pharmaceutical Portfolio of Prasco LLC

in securing investment from

Novast

July 2011

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Pharmagistics, A Division of Publicis

in their acquisition by

J. Knipper & Co

December 2010

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

LIFETREE Clinical Research

in their acquisition by

CRI Worldwide

December 2010

Edgemont Capital Partners
Health Care Services
Advised

Milford Anesthesia Associates

in their acquisition by

Emcare

December 2010

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

QOL Medical

in securing investment from

Cooper Capital

November 2010

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Averion International

in their acquisition by

Trio Clinical Research, Fulcrum Pharma and ClinResearch

September 2010

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Prologue Research

in their acquisition by

Novella Clinical

June 2010

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Triax Media Group

in their acquisition by

PSKW & Associates

February 2010

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

Tillotts Pharma AG

in their acquisition by

Zeria Pharmaceutical

September 2009

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Vince and Associates Clinical Research

in their acquisition by

Gryphon Investors

September 2008

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Synteract

in their acquisition by

Gryphon Investors

September 2008

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Vince and Associates Clinical Research

in securing investment from

Celerity Partners

November 2007

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Alliance Healthcare

in their acquisition by

United Drug

October 2007

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

ARS Inc

in their acquisition by

Premier Research Group

July 2007

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

ValueMedics Research, LLC

in their acquisition by

IMS

March 2007

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

California Clinical Trials

in their acquisition by

PAREXEL International

October 2006

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

Lineberry Research Associates

in their acquisition by

Constella Group

October 2006

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

MedPointe's Doral pharmaceutical product

in securing investment from

Questcor Pharmaceuticals

May 2006

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

UCB’s Gastrocrom pharmaceutical product

in securing investment from

Azur Pharma and Burren Pharmaceuticals

January 2006

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

Questcor Pharmaceutical’s Nascobal pharmaceutical product line

in securing investment from

QOL Medical

October 2005

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

MedSN

in their acquisition by

Indegene

September 2005

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

Hollister-Stier Laboratories’ TwinJect allergy product

in securing investment from

Verus Pharmaceuticals

July 2005

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

Desitin Arzneimittel’s late-stage CNS pharmaceutical product

in securing investment from

U.S. specialty pharmaceutical company

July 2005

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

King Pharmaceuticals' hospital pharmaceutical product portfolio

in securing investment from

Undisclosed Buyer

July 2005

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

PharmAnalysis Group

in their acquisition by

United Biosource Corporation

August 2004

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

POZEN’s MT-300 pharmaceutical product line

in securing investment from

Xcel Pharmaceuticals

September 2003

Edgemont Capital Partners
Pharmaceutical and Medicine Manufacturing
Advised

Nastech Pharmaceutical Company’s Nascobal pharmaceutical product line

in securing investment from

Questcor Pharmaceuticals

June 2003

Edgemont Capital Partners
Research and Development in the Physical, Engineering, and Life Sciences
Advised

CroMedica International

in their acquisition by

PRA International

June 2002

Sectors Edgemont Capital Partners serves:
Health Care
Life Sciences

Join Axial's Private M&A Platform

Edgemont Capital Partners connects with qualified M&A advisors through the Axial Platform.

Selling Your Company?

Find the perfect advisor to help you sell your business.

Find Deals

Grow your deal flow without more headcount.

Member since
2013
Deals they've closed
59
Team (5)
Join as Owner Join as Investor